| Property | Value |
|---|
|
?:abstract
|
-
BACKGROUND COVID-19 is rapidly transmitted and has aroused enormous concern globally. This study aimed to investigate the effect of hydrocolloid dressing combined with 3M Cavilon No-Sting Barrier Film on the prevention of facial pressure injury in medical staff tasked with preventing and controlling COVID-19. METHODS This was a self-controlled study. Medical staff who treated patients with COVID-19 infection in isolation wards from 6 January to 2 February, 2020, were selected to participate. Phase I was defined as the first 2 weeks of medical personnel entering the isolation ward, with phase II being the following 2 weeks. In phase I, medical workers only used hydrocolloid dressing on their faces, and in phase II, they used both hydrocolloid dressing and 3M Cavilon No-Sting Barrier Film. RESULTS A total of 116 medical workers were selected as research subjects. The average facial local temperature in phase I was higher than that in phase II from the baseline (day 1) to the end of the study (day 14); however, there was no statistically significant difference (P>0.05). The incidence of facial pressure injury in phase II was lower than that in phase I (P<0.05); the facial skin comfort level among medical staff in phase II was higher than that in phase I (P<0.05). CONCLUSIONS Hydrocolloid dressing combined with 3M Cavilon No-Sting Barrier Film for facial skin care can effectively reduce the incidence of facial pressure injury and can improve skin comfort level while ensuring isolation and a protective effect.
|
|
?:creator
|
|
|
?:doi
|
|
|
?:doi
|
|
|
?:journal
|
-
Annals_of_palliative_medicine
|
|
?:license
|
|
|
?:pmid
|
|
|
?:pmid
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
?:source
|
|
|
?:title
|
-
Effectiveness of using hydrocolloid dressing combined with 3M Cavilon No-Sting Barrier Film to prevent facial pressure injury on medical staff in a COVID-19 designated hospital in China: a self-controlled study.
|
|
?:type
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}